User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 21 results.
    • Speech
    SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)
    Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphaël Peeters, Marc Holbrechts, Stéphane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand Van Laethem, Jean Luc Ceyssens, Sarah Barbuto, Anna Maria Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Paesmans, Marianne Piccart, Martine Flamen, Patrick (2012) ASCO Annual Meeting — Chicago, Illinois
    • Speech
    SoMore trial: Early metabolic response assessment of a sorafenib (SOR) and capecitabine (CAP) combination in chemorefractory metastatic colorectal cancer (mCRC).
    Deleporte, Amélie Hendlisz, Alain Garcia, Camilo Delaunoit, Thierry Maréchal, Raphael Peeters, Marc Holbrechts, Stephane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand[UCL] Van Laethem, Jean-Luc Rolfo, Christian Diego Diaz, Marie Lhommel, Renaud[UCL] Demolin, Gauthier Moreau, Michel Ameye, Lieveke Paesmans, Marianne Piccart-Gebhart, Martine J. Flamen, Patrick (2014) 2014 ASCO GI Annual Meeting — (United States) San Francisco, CA
    • Journal article
    Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.
    Vandeputte, Caroline Bregni, Giacomo Gkolfakis, Paraskevas Guiot, Thomas Pretta, Andrea Kehagias, Pashalina Senti, Chiara Reina, Elena Acedo Van Bogaert, Camille Deleporte, Amélie Geboes, Karen Delaunoit, Thierry Demolin, Gauthier Peeters, Marc D'Hondt, Lionel[UCL] Janssens, Jos Carrasco, Javier Holbrechts, Stephane Goeminne, Jean-Charles[UCL] Vergauwe, Philippe Van Laethem, Jean-Luc Flamen, Patrick Hendlisz, Alain Sclafani, Francesco (2021) Clinical colorectal cancer — Vol. 20, no. 4, p. 326-333 (2021)
    • Speech
    Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.
    Van den Eynde, Marc[UCL] Castella, Marie-Laure[UCL] Machiels, Jean-Pascal[UCL] Humblet, Yves[UCL] Canon, Jean-Luc Houbiers, Ghislain Demolin, Gauthier D'Hondt, Lionel[UCL] Coche, Jean-Charles Van Daele, Daniel Delaunoit, Thierry Goeminne, Jean-Charles Benuiga, Gabriella Pairet, Géraldine Sempoux, Christine[UCL] Mourin, Anne[UCL] van Maalen, Aline[UCL] Carrasco, Javier (2015) 2015 ASCO GI — (United States) San Francisco, CA
    • Speech
    An exploratory analysis based on tumor location of REACHIN, a randomized double-blinded placebo-controlled phase II trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tract tumors.
    Demols, Anne Borbath, Ivan[UCL] Van den Eynde, Marc[UCL] Houbiers, Ghislain Peeters, Marc Maréchal, Raphaël Delaunoit, Thierry Goeminne, Jean Charles. Laurent, Stéphanie Holbrechts, Stephane Paesmans, Marianne Van Laethem, Jean-Luc (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (NONCOLORECTAL) CANCER —
    • Journal article
    Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
    Hendlisz, Alain Van den Eynde, Marc[UCL] Peeters, Marc Maleux, Geert Lambert, Bieke Vannoote, Jaarke De Keukeleire, Katrien Verslype, Chris Defreyne, Luc Van Cutsem, Eric Delatte, Philippe Delaunoit, Thierry Personeni, Nicola Paesmans, Marianne Van Laethem, Jean-Luc Flamen, Patrick (2010) Journal of Clinical Oncology — Vol. 28, no. 23, p. 3687-3694 (2010)
    • Journal article
    Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial.
    Demols, Anne Borbath, Ivan[UCL] Van Den Eynde, Marc[UCL] Houbiers, Ghislain Peeters, Marc Marechal, Raphäel Delaunoit, Thierry Goemine, Jean-Charles Laurent, Stéphanie Holbrechts, Stéphane Paesmans, Marianne Van Laethem, Jean-Luc (2020) Annals of oncology — Vol. 31, no.9, p. 1169-1177 (2020)
    • Journal article
    Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.
    Van den Heuvel, Bert Peeters, Marc Hendlisz, Alain Van den Eynde, Marc[UCL] Machiels, Godelieve Dero, Isabel Geboes, Karen De Man, Marc Hendrickx, Koen Delaunoit, Thierry Monsaert, Els Vanderstraten, Erik Van Laethem, Jean L Lybaert, Willem Holbrechts, Stephane Rolfo, Christian (2016) Minerva Chirurgica : a journal on surgery — Vol. 71, p. 91-97 (2016)
    • Journal article
    Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.
    Woff, Erwin Hendlisz, Alain Garcia, Camilo Deleporte, Amelie Delaunoit, Thierry Maréchal, Raphaël Holbrechts, Stéphane Van den Eynde, Marc[UCL] Demolin, Gauthier Vierasu, Irina Lhommel, Renaud[UCL] Gauthier, Namur Guiot, Thomas Ameye, Lieveke Flamen, Patrick (2016) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 43, p. 1792-1801 (2016)
    • Journal article
    The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
    Hendlisz, Alain Deleporte, Amelie Delaunoit, Thierry Maréchal, Raphaël Peeters, Marc Holbrechts, Stéphane Van den Eynde, Marc[UCL] Houbiers, Ghislain Filleul, Bertrand Van Laethem, Jean-Luc Ceyssens, Sarah Barbuto, Anna-Maria Lhommel, Renaud[UCL] Demolin, Gauthier Garcia, Camilo ElMansy, Hazem[UCL] Ameye, Lieveke Moreau, Michel Guiot, Thomas Paesmans, Marianne Piccart, Martine Flamen, Patrick Santini, Daniele (2015) PLoS One — Vol. 10, no. 9, p. e0138341[1-14] (2015)
    • Journal article
    Adenocarcinoma arising in gastric heterotopic pancreas. Case report and review of the literature
    Lemaire, Julien[UCL] Delaunoit, Thierry Molle, Gaëtan (2014) Acta Chirurgica Belgica (Bilingual Edition) — Vol. 114, no. 1, p. 79-81 (2014)
    • Journal article
    Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
    Borbath, Ivan[UCL] Ceratti, Antonino[UCL] Verslype, Chris Demols, Anne Delaunoit, Thierry Laurent, Stéphanie Deleporte, Amélie Vergauwe, Philippe L Van Maanen, Aline[UCL] Sempoux, Christine[UCL] Van Cutsem, Eric Van Laethem , Jean Luc Belgian Group of Digestive Oncology (2013) Annals of Oncology — Vol. 24, no.11, p. 2824-2829 (2013)
    • Journal article
    Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer
    Mardjuadi, Feby[UCL] Carrasco, Javier[UCL] Coche, Jean-Charles Sempoux, Christine[UCL] Jouret-Mourin, Anne[UCL] Scalliet, Pierre[UCL] Goeminne, Jean-Charles Daisne, Jean-François Delaunoit, Thierry Vuylsteke, Peter Humblet, Yves[UCL] Meert, Nicolas Van den Eynde, Marc[UCL] Moxhon, Anne[UCL] Haustermans, Karin Canon, Jean-Luc[UCL] Machiels, Jean-Pascal[UCL] (2015) Targeted Oncology : biotherapies for the clinicians in oncology — Vol. 10, no. 3, p. 375-383 (2015)
    • Speech
    Phase II trial of preoperative radiotherapy (RT) and panitumumab (PAN) in KRAS wild type (wt) rectal cancer (RC).
    Mardjuadi, Feby Ingriani Canon, Jean-Luc Coche, Jean-Charles Jouret-Mourin, Anne[UCL] Sempoux,Christine Goeminne, Jean-Charles Delaunoit, Thierry Carrasco, Javier Vuylsteke, Peter Humblet, Yves[UCL] Meert, Nicolas Van den Eynde, Marc[UCL] Moxhon, Anne[UCL] Machiels, Jean-Pascal[UCL] (2012) 2012 ASCO Annual Meeting I - GASTROINTESTINAL (COLORECTAL) CANCER —
    • Speech
    Weekly versus biweekly combination of docetaxel (d)-cisplatin (c)-5fu (f) in advanced gastric cancer and esogastric junction adenocarcinoma (agc): doge study
    Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, F. Holbrechts, Stephane Delaunoit, Thierry Houbiers, Ghislain Kalantari, H. Rezaei Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Vanderauwera, J. Pierre, Pascal D'Hondt, Lionel[UCL] Ghillemijn, Bjorn Covas, Angélique Paesmans, Marianne Ameye, Lieveke Hendlisz, Alain (2014) 39th ESMO Congress (ESMO 2014) — (Spain) Madrid
    • Journal article
    Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.
    Deleporte, Amélie Van den Eynde, Marc[UCL] Forget, Frédéric Holbrechts, Stéphane Delaunoit, Thierry Houbiers, Ghislain Kalantari, Hassan R Laurent, Stéphanie Vanderstraeten, Erik De Man, Marc Vergauwe, Philippe Clausse, Marylene Van Der Auwera, Jacques D'Hondt, Lionel[UCL] Pierre, Pascal Ghillemijn, Bjorn Covas, Angelique Paesmans, Marianne Ameye, Lieveke Awada, Ahmad Sclafani, Francesco Hendlisz, Alain (2021) Cancer medicine — Vol. 10, no. 13, p. 4366-4374 (2021)
    • Speech
    SOMORE trial: combining sorafenib with capecitabine yields highly encouraging survival results and elevated metabolic response rate in chemorefractory metastatic colorectal cancer
    Deleporte, Amélie Hendlisz, Alain Delaunoit, Thierry Maréchal, Raphael Peeters, Marc Holbrecht, Stephane Van den Eynde, Marc[UCL] Houbiers, Ghislain Moreau, Michel Flamen, Patrick (2012) ESMO 2012 Congress — (Austria) Vienna
    • Speech
    Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study
    Cerrati, Antonino[UCL] Borbath, Ivan[UCL] Verslype, Chris Delaunoit, Thierry Van den Eynde, Marc[UCL] Laurent, Stéphanie Peeters, Marc Hendlisz, Alain Deleporte, Amélie Vergauwe, Philippe Delhougne, Bernard Polus, Marc Van Cutsem, Eric Van Laethem, Jean-Luc (2011) Belgian Week of Gastroenterology - XXIIIrd Edition — (Belgium) Liege
    • Journal article
    Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.
    Vandeputte, Caroline Kehagias, Pashalina El Housni, Hakim Ameye, Lieveke Laes, Jean-François Desmedt, Christine Sotiriou, Christos Deleporte, Amélie Puleo, Francesco Geboes, Karen Delaunoit, Thierry Demolin, Gauthier Peeters, Marc D'Hondt, Lionel[UCL] Janssens, Jos Carrasco, Javier Marechal, Raphaël Galdon, Maria Gomez Heimann, Pierre Paesmans, Marianne Flamen, Patrick Hendlisz, Alain (2018) OncoTarget — Vol. 9, no.25, p. 17756-17769 (2018)
    • Speech
    Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC): REGARD-C study.
    Hendlisz, Alain Deleporte, Amélie Delaunoit, Thierry Peeters, Marc Demolin, Gauthier Janssens, Jos Holbrechts, Stephane Maréchal, Raphael Carrasco, Javier Van den Eynde, Marc[UCL] Geboes, Karen Paula Goeminne, Jean-Charles D'Hondt, Lionel[UCL] Paesmans, Marianne Vandeputte, Caroline Hoerner, Frederic Flamen, Patrick (2014) 2014 ASCO Annual Meeting — (United States) Chicago, IL
    • Speech
    Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial.
    Demols, Anne Borbath, Ivan[UCL] Van den Eynde, Marc[UCL] Houbiers, Ghislain Peeters, Marc Maréchal, Raphael Delaunoit, Thierry Goeminne, Jean Charles. Laurent, Stéphanie Holbrechts, Stephane Paesmans, Marianne Van Laethem, Jean L. (2019) ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium — (United States) San Francisco, CA